揭示性结肠炎和动脉样硬化之间的共享分子和机制:综合基因组分析
Jinke Huang1,2, Fengyun Wang1,2, Xudong Tang2
1Department of Gastroenterology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
不平衡的免疫反应驱动性结肠炎 (UC) 和动脉样硬化 (AS) 共同疾病. 蛋白氨酸酸酶,受体类型,C (PTPRC) 被确定为这些相关的炎症性疾病的关键生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 性结肠炎 (UC) 和动脉样硬化 (AS) 分享复杂的病理机制.
- 了解UC和AS并发症的分子基础对于向治疗至关重要.
研究的目的:
- 确定UC和AS共同发生的关键分子参与者和机制.
- 探索UC和AS共发病的潜在生物标志物.
主要方法:
- 差异基因表达分析确定了UC和AS之间的共享基因.
- 网络分析确切地确定了枢纽基因,包括蛋白氨酸酸酶,受体类型,C (PTPRC).
- 进行了免疫透和基因组丰富分析 (GSEA).
主要成果:
- 确定了59个共享的差异表达基因 (DEG),主要涉及免疫和炎症途径.
- PTPRC被确定为一个关键的交叉基因,其上调与特定的免疫细胞群相关.
- 高PTPRC表达与NF-kappa B信号传递等炎症途径相关.
结论:
- 转录分析表明,失调的免疫和炎症反应是UC和AS并发症的核心.
- PTPRC成为UC和AS同时发生的重要生物标志物.
更多相关视频
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Drugs for Treatment of Ulcerative Colitis in IBD
Atherosclerosis I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
